A patient with brief, sharp mid‑upper abdominal pain after meals and when supine, who has stopped taking Adderall, how should the pain be evaluated and managed?

Evaluation and Management of Brief, Sharp Mid-Upper Abdominal Pain After Meals and When Supine

This patient's symptoms—brief, sharp mid-upper abdominal pain triggered by meals and supine positioning—most likely represent functional dyspepsia (specifically epigastric pain syndrome) or gastroesophageal reflux disease, and should be evaluated with H. pylori testing followed by an empiric PPI trial if no alarm features are present.

Initial Clinical Assessment

The symptom pattern described fits the Rome IV clinical criteria for functional dyspepsia (FD), particularly the epigastric pain syndrome (EPS) subtype, which presents as epigastric pain or burning that may be induced by meals or occur while fasting 1. The positional component (worse when supine) raises consideration of GERD as a coexisting or alternative diagnosis 2.

Key Historical Elements to Obtain

• Age and alarm features: Urgent endoscopy is indicated if age ≥55 years with weight loss, or age ≥55 years with treatment-resistant dyspepsia 1
• Pain characteristics: In FD, pain is typically in the upper abdomen/epigastrium, unrelated to defecation (unlike IBS), and may be meal-related 1
• Medication history: NSAIDs are strongly associated with dyspepsia and should be discontinued if possible 1
• Red flags: Dysphagia, hematemesis, unintentional weight loss, or family history of gastroesophageal cancer warrant urgent evaluation 1
• Positional symptoms: Pain worse when supine or after meals suggests possible GERD component or mechanical reflux 2

Note on Adderall Discontinuation

While the patient has stopped Adderall, stimulant medications can cause decreased appetite and gastrointestinal symptoms 3. However, these symptoms typically improve after discontinuation, so persistent pain after stopping suggests an independent gastrointestinal etiology rather than medication effect.

Diagnostic Workup

Baseline Investigations Required

For patients without alarm features:

• H. pylori testing (stool antigen or breath test) - all patients with FD should be tested 1
• Full blood count if age ≥55 years 1
• Coeliac serology if overlapping IBS-type symptoms present 1

When to Pursue Imaging

Abdominal ultrasound should be considered if pain has characteristics of biliary colic (episodic, lasting 30+ minutes, right upper quadrant predominant) 1.

Endoscopy is NOT immediately indicated unless:

• Age ≥55 years with weight loss 1
• Treatment-resistant symptoms after appropriate therapy trial 1
• Alarm features present (dysphagia, hematemesis, family history of gastroesophageal cancer) 1

Management Algorithm

Step 1: H. pylori Testing and Eradication (if positive)

All patients should receive H. pylori testing as first-line management 1. If positive, provide antibiotic eradication therapy and reassess symptoms after treatment completion.

Step 2: Empiric PPI Trial (if H. pylori negative or symptoms persist post-eradication)

Provide a 4-8 week trial of once-daily PPI taken 30-60 minutes before a meal 2. Any commercially available PPI is appropriate initially. This approach has ~70% sensitivity and specificity for pathologic GERD and provides high therapeutic gain for typical symptoms 2.

If inadequate response after 4-8 weeks:

• Increase to twice-daily dosing, OR
• Switch to more potent PPI (rabeprazole, esomeprazole, or dexlansoprazole) 2

If adequate response:

• Taper to lowest effective dose 2
• Consider on-demand or intermittent therapy

Step 3: Adjunctive Lifestyle Modifications

• Elevate head of bed for positional symptoms 2
• Avoid meals within 3 hours of bedtime 2
• Weight management if overweight/obese 2
• Avoid trigger foods that reproducibly worsen symptoms 1
• Smoking cessation (smoking is a risk factor for postprandial distress syndrome) 1

Step 4: Consider Neuromodulators if PPI-Refractory

If symptoms persist despite adequate PPI trial and H. pylori management, tricyclic antidepressants (TCAs) or other neuromodulators may be beneficial for functional dyspepsia, as they address visceral hypersensitivity 1. This represents treatment of the gut-brain axis dysfunction underlying FD 1.

Critical Pitfalls to Avoid

1. Do not delay H. pylori testing: This is first-line for all dyspepsia patients and changes management 1

2. Do not over-investigate young patients without alarm features: 80% of dyspepsia patients have functional dyspepsia after endoscopy; empiric treatment is appropriate initially 1

3. Do not attribute symptoms solely to prior Adderall use: While stimulants cause GI symptoms, persistent pain after discontinuation suggests independent pathology requiring evaluation 3

4. Do not restrict diet excessively: There is no evidence for specialized diets in FD, and excessive restriction risks malnutrition 1

5. Recognize that normal endoscopy does not mean "nothing is wrong": FD represents gut-brain axis dysfunction with altered visceral sensitivity, not absence of pathology 1

When to Refer for Endoscopy

Proceed to endoscopy if:

• Age ≥55 years with any of: weight loss, treatment-resistant symptoms, or elevated platelet count 1
• Any alarm features present 1
• Symptoms persist despite appropriate H. pylori management and adequate PPI trial 2